A pilot study of β-interferon for treatment of patients with chronic hepatitis B who failed to respond to α-interferon

Journal of Hepatology

Volumn 37, Issue 5, 2002, Pages 655-659

  Muoz, Raquel ^a   Castellano, Gregorio ^a   Fernández, Inmaculada ^a   Álvarez, Maria Victoria ^a   Manzano, Maria Luisa ^a   Marcos, Maria Soledad ^a   Cuenca, Beatriz ^b   Solís Herruzo, José A ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

Author keywords

Interferon therapy; Chronic hepatitis B; Safety

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALPHA INTERFERON; AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BETA INTERFERON; BILIRUBIN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; PROTEIN; VIRUS DNA; ANTIVIRUS AGENT;

ADULT; ALOPECIA; ARTHRALGIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; ENZYME IMMUNOASSAY; ERYTHEMA; FATIGUE; FEMALE; FLU LIKE SYNDROME; FOLLOW UP; HEADACHE; HEPATITIS B; HUMAN; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; INSOMNIA; LIVER BIOPSY; MALE; MYALGIA; NAUSEA; NEUTROPENIA; PRIORITY JOURNAL; RADIOIMMUNOASSAY; THROMBOCYTOPENIA; TREATMENT FAILURE; ANTIBIOTIC RESISTANCE; BLOOD; CLINICAL TRIAL; DRUG EFFECT; HEPATITIS B VIRUS; MIDDLE AGED; PILOT STUDY; TREATMENT OUTCOME;

ADULT; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; DRUG RESISTANCE, VIRAL; FEMALE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INTERFERON-ALPHA; INTERFERON-BETA; MALE; MIDDLE AGED; PILOT PROJECTS; TREATMENT OUTCOME;

EID: 0036845813     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(02)00261-1     Document Type: Article

References (30)

1. Weissberg JI, Ljudevit LA, Coleman IS, Weick S, Nichols JE, Garcia G, et al. Survival in chronic hepatitis B: An analysis of 379 patients. Ann Intern Med 1984;101:613-616.
2. Beasley R, Lin C, Hwang L, Chein C. Hepatocellular carcinoma and hepatitis B virus. Lancet 1981;2:1129-1133.
3. Niederau C., Heintges T, Lange S, Goldman G, Niederau GM, Mohr L, et al. Long term follow-up of HBeAg positive patients treated with interferon alfa for chronic hepatitis B. N Engl J Med 1996;334:1422-1427.
4. Lau DT, Everhart J, Kleiner DE, Park Y, Vergalla J, Schrnid P, et al. Long-term follow-up of patients with chronic hepatitis B treated with interferon alfa. Gastroenterology 1997;113:1660-1667.
5. Torresi J, Locarnini S. Antiviral chemotherapy for the treatment of hepatitis B virus infection. Gastroenterology 2000;118:83-103.
6. Perrillo RP, Schitt ER, Davis GL, Bodenheimer Jr HC, Lindsay K, Payne J, et al. A randomized, controlled trial of interferon in patients with chronic hepatitis B. The Hepatitis International Therapy Group. N Engl J Med 1990;323:295-301.
7. Dienstag JL, Schiff ER, Wright TL, Perrillo RP, Hann HW, Goodman Z, et al. Lamivudine as initial treatment for chronic hepatitis B in the United States. N Engl J Med 1999;341:1256-1263.
8. Tassopoulos NC, Volpes R, Pastore G, Heathcote J, Buti M, Goldin RD, et al. Efficacy of lamivudine in patients with hepatitis B antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B. Hepatology 1999;29:889-896.
9. Lau DT, Khokhar MF, Doo E, Ghany MG, Herion D, Park Y, et al. Long-term therapy of chronic hepatitis B with lamivudine. Hepatology 2000;32:828-834.
10. Mutimer D, Naoumov N, Honkoop P, Marinos G, Ahmed M, De Man R, et al. Combination alpha interferon and lamivudine therapy for alpha interferon resistant chronic hepatitis B infection: Results of a pilot study. J Hepatol 1998;28:923-929.
11. Berk L, Schalm SW, de Man RA, Heytink RA, Berthelot P, Brechot C, et al. Failure of acyclovir to enhance the antiviral effect of alpha lymphoblastoid interferon on HBe-seroconversion in chronic hepatitis B. A multi-centre randomized controlled trial. J Hepatol 1992;14:305-309.
12. Janssen HLA, Berk L, Heijtink RA, Ten Kate FJW, Schalm SW. Interferon-alpha and zidovudine combination therapy for chronic hepatitis B: Results of a randomized, placebo-controlled trial. Hepatology 1993;17:383-388.
13. Kakumu S, Yoshioka K, Wakita T, Ishikawa T, Takayanagi M, Higashi Y. Pilot study of ribavirin and interferon-beta for chronic hepatitis B. Hepatology 1993;18:258-263.
14. Janssen HLA, Schalm SW, Berk L, de Man RA, Heijtink RA. Repeated courses of alpha-interferon for treatment of chronic hepatitis type B. J Hepatol 1993;17:47-51.
15. Weissmann C, Weber M. The interferon genes. Prog Nucleic Acid Res Mol Biol 1986;33:251-300.
16. Weinstock-Guttman B, Jacobs LD. What is new in the treatment of multiple sclerosis? Drugs 2000;59:401-410.
17. Kagawa T, Morizane T, Saito H, Tsunematsu S, Tada S, Kumagai N, et al. A pilot study of long-term weekly interferon β administration for chronic hepatitis B. Am J Gastroenterol 1993;88:212-216.
18. Ruiz M, Fernández P, Leal A, Bartolomé J, Castillo I, Oliva H, et al. Pilot interferon β trial in children with chronic hepatitis B who had previously not responded to interferon α therapy. Pediatrics 1997;99:222-225.
19. Mantero G, Zonaro A, Albertini A, Bertolo P, Primi D. DNA enzyme immunoassay: General method for detecting products of polymerase chain reaction. Clin Chem 1991;37:422-429.
20. Scheuer PJ. Classification of chronic viral hepatitis: A need for reassessment. J Hepatol 1991;13:372-374.
21. Oliveri F, Santantonio T, Bellati G, Colombatto P, Colloredo G, Carriero L, et al. Long term response to therapy of chronic anti-HBe positive hepatitis B is poor independent of type and schedule of interferon. Am J Gastroenterol 1999;94:1366-1372.
22. Brunetto MR, Oliveri F, Rocca G, Criscuolo D, Chiaberge E, Capalbo M, et al. Natural course and response to interferon of chronic hepatitis B accompanied by antibody to hepatitis B e antigen. Hepatology 1989;10:198-202.
23. Hadziyannis S, Bramou T, Makris A, Moussoulis G, Zignego L, Papaioannou C. Interferon α-2b treatment of HBeAg negative/serum HBV-DNA positive chronic hepatitis type B. J Hepatol 1990;11(Suppl. 1):S133-S136.
24. Fattovich G, Farci P, Rugge M, Brollo L, Mandas A, Pontisso P, et al. A randomized controlled trial of lymphoblastoid IFN alpha in patients with chronic hepatitis B lacking HBeAg. Hepatology 1992;15:584-589.
25. Pastore G, Santantonio T, Milella M, Monno L, Mariano N, Moschetta R, et al. Anti-HBe positive chronic hepatitis B with HBV-DNA in the serum: Response to a 6 month course of lymphoblastoid IFN. J Hepatol 1992;14:221-225.
26. Fernández I, Castellano G, Manzano ML, Colina F, Canga F, Muñoz R, et al. Twelve months interferon-α therapy induces a similar sustained response in anti-HBe-positive and HBeAg-positive chronic hepatitis B patients. Hepatogastroenterolgy 2000;47:1351-1355.
27. Carreno V, Marcelin P, Hadziyannis S, Salmeron J, Diago M, Kitis GE, et al. Retreatment of chronic hepatitis B e antigen-positive patients with recombinant interferon alpha-2a. Hepatology 1999;30:277-282.
28. Lai CL, Chien RN, Leung NW, Chang TT, Guan R, Tai DI, et al. A 1-year trial of lamivudine for chronic hepatitis B. N Engl J Med 1998;339:61-68.
29. Cotonat T, Quiroga JA, López-Alcorocho JM, Clouet R, Pardo M, Manzabeitia F, et al. Pilot study of combination therapy with ribavirin and interferon alfa for the retreatment of chronic hepatitis B e antibody-positive patients. Hepatology 2000;31:502-506.
30. Porres JC, Carreño V, Ruiz-Moreno M, Marrón JA, Bartolomé J. Interferon antibodies in patients with recombinant interferon. J Hepatol 1989;8:351-357.